Evelyn Partners Investment Management (Europe) LTD Abbott Laboratories Transaction History
Evelyn Partners Investment Management (Europe) LTD
- $289 Billion
- Q3 2025
A detailed history of Evelyn Partners Investment Management (Europe) LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Evelyn Partners Investment Management (Europe) LTD holds 675 shares of ABT stock, worth $87,770. This represents 0.03% of its overall portfolio holdings.
Number of Shares
675
Previous 425
58.82%
Holding current value
$87,770
Previous $91.7 Million
1.45%
% of portfolio
0.03%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,655Shares Held
1.38BCall Options Held
10.4MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...